Active Filters
- Press ReleaseClear filter
Oct 23, 2024
myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across U.S. and Canada
Oct 16, 2024
Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma
Oct 2, 2024
In surgery for localized muscle-invasive bladder cancer, extended lymph node removal offers no survival benefit but does increase morbidity
Sep 24, 2024
A new validated risk model identifies advanced cancer trial patients at highest risk for acute care use
Sep 20, 2024
Adding ruxolitinib to TKI treatment for chronic-phase chronic myeloid leukemia (CML) increases deep molecular response rate
Jul 26, 2024
Tumors with alterations in any of three specific DNA damage-repair genes were more likely than other tumors to be eliminated by cisplatin-based chemotherapy.
Mar 6, 2024
Pilot confirms acceptability of bowel symptom intervention for survivors of rectal cancer